The following is a summary of the Reckitt Benckiser Group Plc (RBGPF) Q1 2024 Earnings Call Transcript:

Financial Performance:

• Reckitt Benckiser reported a like-for-like net volume increase of 1.4% across their Hygiene and Health portfolios in Q1 2024.

• The Nutrition division experienced a 9.9% decline in net revenue, caused by a negative volume of 9.4% and a 0.5% drop from price/mix.

• Hygiene business saw a 7.1% like-for-like net revenue increase, majorly contributed by Finish and Lysol brands.

• Health segment saw a 1% increase in like-for-like net revenue led by Durex, Dettol, VMS, and Gaviscon brands.

• Reckitt Benckiser's revenue and profit guidance are heavily weighted towards H2, indicating expected margin growth during this period.

Business Progress:

• North America saw growth in hygiene brands in Q1 2024, developing markets such as India and China experienced mid-single-digit volume growth.

• Reckitt Benckiser's innovations, like Durex Invisible and recently launched Lysol Air Sanitizer, are stimulating growth.

• High performing areas such as OTC, Intimate wellness, and Finish will continue to receive investment for continued growth.

• The accelerated share buyback program has seen £600 million of shares purchased to date, with another round expected to commence in July.

• The company plans to launch new innovations and platforms over the next year, promoting portfolio advancement and shareholder value.

• Progress in their strategic agenda is ongoing, with an update expected in their half-year results. Despite being involved in a complex litigation process, Reckitt Benckiser remains committed to its current strategic path.

More details: RECKITT BENCKISER GROUP PLC IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.